Emergence of a novel GII.17 variant is associated with immune evasion rather than an altered HBGA-binding profile
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014522 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Stefan T van der Krieken und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Immune Evasion, Norovirus, Blood Group Antigens, Caliciviridae Infections. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council (NWO), European Union’s Horizon Europe Research and Innovation Programme, NWO Stevin Prize 2018.
Abstract (Originalsprache)
The epidemiology of noroviruses, a major cause of gastroenteritis in humans, is shaped by their continuous evolution. Novel genotypes and variants periodically emerge, replacing previously dominant strains. In 2024, a novel GII.17 variant led to an increased number of notified outbreaks, becoming the dominant genotype detected in Europe. To investigate if this surge in GII.17 detection is attributable to changes in the binding and antigenicity of this novel variant, we compared properties of a GII.17 2024 strain with representative GII.17 strains from 2005 (Clade B), 2014 (Clade C), and 2015 (Clade D), and the epidemic GII.4 Sydney 2012 variant. Norovirus virus-like particles (VLPs) were used to assess binding to saliva samples and human intestinal tissues with different histo-blood group antigen (HBGA) profiles. Binding specificity to individual glycans was determined using synthetic HBGAs. Additionally, VP1-NanoLuc (NLuc) fusion proteins were used in binding blocking assays to evaluate the antigenic properties of the variants using 75 sera from healthy adults that were collected during different time periods of GII.17 circulation (the winters of 2009–2010, 2015 and 2024). Compared with other GII.17 variants, the 2024 strain exhibited amino acid substitutions in the P2 domain, which contains both antigenic sites and the HBGA binding site. Binding-blocking assays with human sera confirmed that the 2024 variant is antigenically distinct from the 2005 and 2015 GII.17 strains but closely related to the 2014 variant. All post-2005 GII.17 strains showed a broader HBGA binding profile compared to the GII.17 2005 strain, likely contributing to their more successful spread. These findings show that the recent re-emergence of GII.17 coincided with antigenic drift, enabling it to escape from pre-existing immunity, but not with major changes in HBGA binding specificity. Understanding the factors influencing norovirus emergence is essential for the development of preventive strategies against future norovirus epidemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
- Institute of Biochemistry and Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Hannover, Germany.
- Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
- Electron Microscopy Facility, Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.
- Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, Netherlands.
ORCID-Profile: Miranda de Graaf
Förderung
- Dutch Research Council (NWO)
- European Union’s Horizon Europe Research and Innovation Programme
- NWO Stevin Prize 2018
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- EU4Health
Zitieren
APA
van der Krieken, S. T., Morais Esteves, F., Villabruna, N., Schapendonk, C. M. E., Izquierdo-Lara, R. W., Fajar, P. A., Leijten, L., de Jong, A., Koning, R. I., Doukas, M. C., GeurtsvanKessel, C. H., Koopmans, M. P. G., & de Graaf, M. (2026). Emergence of a novel GII.17 variant is associated with immune evasion rather than an altered HBGA-binding profile. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014522
Vancouver
van der Krieken ST, Morais Esteves F, Villabruna N, Schapendonk CME, Izquierdo-Lara RW, Fajar PA, et al. Emergence of a novel GII.17 variant is associated with immune evasion rather than an altered HBGA-binding profile. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014522
BibTeX
@article{vanderKrieken2026,
author = {van der Krieken, Stefan T and Morais Esteves, Francisco and Villabruna, Nele and Schapendonk, Claudia M E and Izquierdo-Lara, Ray W and Fajar, Putri Ayu and Leijten, Lonneke and de Jong, Anja and Koning, Roman I and Doukas, Michail C and GeurtsvanKessel, Corine H and Koopmans, Marion P G and de Graaf, Miranda},
title = {Emergence of a novel GII.17 variant is associated with immune evasion rather than an altered HBGA-binding profile},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014522}
}
EUVIMED